Miranda-Scippa Â

Language: Portugu?s
References: 5
Page: 6-8
PDF size: 285.04 Kb.

Text Extraction

No abstract.

REFERENCES

1. World Health Organization (WHO). International Classification of Diseases 11 (ICD) for Mortality and Morbidity Statistics. 11th ed. Chapter 06. Mental, Behavioural or Neurodevelopmental Disorders, p. 22-30. Geneva: WHO; 2018.

2. Jones S, Riste L, Barrowclough C, Bartlett P, Clements C, Davies L, et al. Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Suicidality) Programme. Southampton (UK): NIHR Journals Library; 2018. v. 6. p. 1-332.

3. Schaffer A, Isometsa ET, Tondo L, Moreno D, Turecki G, Reis C, et al. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord. 2015;17(1):1-16.

4. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170.

5. Baldessarini R, Leonardo T, Vazquez G. Pharmacological treatment of bipolar disorders. Mol Psychiatry. 2019 Feb;24(2):198-217.